Overview

The Thiamine Administration After Cardiac Surgery Trial

Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Thiamine (Vitamin B1) is essential for cell function and as a co-factor of the enzyme Pyruvate Dehydrogenase to initiate the Krebs cycle and thus the aerobic metabolism of glucose. We hypothesize that thiamine supplementation improves the clearance of lactate in the first 24 hours after cardiac surgery with extracorporeal circulation in patients with high lactate concentration.
Phase:
Phase 4
Details
Lead Sponsor:
Sarah Saxena
Collaborator:
CHU de Charleroi
Treatments:
Thiamine